Hospira Announces Urgent Nationwide Medical Device Correction For Gemstar Docking Station

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Hospira Announces Urgent Nationwide Medical Device Correction For Gemstar Docking Station

05/02/2014 02:57 PM EDT

Hospira, Inc. (NYSE: HSP), announced today a nationwide medical device correction of the GemStar™ Docking Station (list number 13075), used in conjunction with the GemStar infusion pump. The correction is being taken following customer reports of two potential malfunctions that may occur with the GemStar Docking Station.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420